Search research articles
Contact Us
Filters
Showing results (201-210 of 247) with videos related to
Page
of 25
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2026
Dose Escalation With Intensity-Modulated Proton Therapy for Patients with High-Risk Meningiomas - Results From a Phase 1 Trial
Felix Ehret, Nora K Horick, Beow Y Yeap, et al.
Cancer
|
January 15, 2015
Proton therapy for low-grade gliomas: Results from a prospective trial
Helen A Shih, Janet C Sherman, Lisa B Nachtigall, et al.
The Oncologist
|
October 31, 2018
Enrichment of <i>HER2</i> Amplification in Brain Metastases from Primary Gastrointestinal Malignancies
Devarati Mitra, Jeffrey W Clark, Helen A Shih, et al.
Toxicology
|
April 22, 2008
Integration of in vivo and in vitro approaches to characterize the toxicity of Antalarmin, a corticotropin-releasing hormone receptor antagonist
Thomas L Horn, J Brooks Harder, William D Johnson, et al.
Journal of Neurosurgery
|
January 22, 2026
Protocol for the systematic reduction of sterile surgical instrument waste: a single-institution prospective implementation and analysis
Timothy R West, Nicole A Perez, Kwaku Adubofour, et al.
Journal for Immunotherapy of Cancer
|
November 16, 2019
CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma
Bryan D Choi, Xiaoling Yu, Ana P Castano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 14, 2020
<i>TERT</i> Promoter Mutation Analysis for Blood-Based Diagnosis and Monitoring of Gliomas
Koushik Muralidharan, Anudeep Yekula, Julia L Small, et al.
World Neurosurgery
|
October 13, 2019
Atypical Histopathological Features and the Risk of Treatment Failure in Nonmalignant Meningiomas: A Multi-Institutional Analysis
Nayan Lamba, William L Hwang, Daniel W Kim, et al.
Neurosurgery
|
November 28, 2018
A Clinical Rule for Preoperative Prediction of BRAF Mutation Status in Craniopharyngiomas
Shingo Fujio, Tareq A Juratli, Kazunori Arita, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2014
Targetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomas
Hiroaki Wakimoto, Shota Tanaka, William T Curry, et al.
Page
of 25
Search research articles
Search
Showing results (201-210 of 247) with videos related to
Sort By:
Page
of 25
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2026
Dose Escalation With Intensity-Modulated Proton Therapy for Patients with High-Risk Meningiomas - Results From a Phase 1 Trial
Felix Ehret, Nora K Horick, Beow Y Yeap, et al.
Cancer
|
January 15, 2015
Proton therapy for low-grade gliomas: Results from a prospective trial
Helen A Shih, Janet C Sherman, Lisa B Nachtigall, et al.
The Oncologist
|
October 31, 2018
Enrichment of <i>HER2</i> Amplification in Brain Metastases from Primary Gastrointestinal Malignancies
Devarati Mitra, Jeffrey W Clark, Helen A Shih, et al.
Toxicology
|
April 22, 2008
Integration of in vivo and in vitro approaches to characterize the toxicity of Antalarmin, a corticotropin-releasing hormone receptor antagonist
Thomas L Horn, J Brooks Harder, William D Johnson, et al.
Journal of Neurosurgery
|
January 22, 2026
Protocol for the systematic reduction of sterile surgical instrument waste: a single-institution prospective implementation and analysis
Timothy R West, Nicole A Perez, Kwaku Adubofour, et al.
Journal for Immunotherapy of Cancer
|
November 16, 2019
CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma
Bryan D Choi, Xiaoling Yu, Ana P Castano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 14, 2020
<i>TERT</i> Promoter Mutation Analysis for Blood-Based Diagnosis and Monitoring of Gliomas
Koushik Muralidharan, Anudeep Yekula, Julia L Small, et al.
World Neurosurgery
|
October 13, 2019
Atypical Histopathological Features and the Risk of Treatment Failure in Nonmalignant Meningiomas: A Multi-Institutional Analysis
Nayan Lamba, William L Hwang, Daniel W Kim, et al.
Neurosurgery
|
November 28, 2018
A Clinical Rule for Preoperative Prediction of BRAF Mutation Status in Craniopharyngiomas
Shingo Fujio, Tareq A Juratli, Kazunori Arita, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2014
Targetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomas
Hiroaki Wakimoto, Shota Tanaka, William T Curry, et al.
Page
of 25